Rachel Britt, PharmD, BCIDP, provides insights on an evolving understanding of the long-time antibiotic’s limitations for these infections and provides guidance on other agents and the role of diagnostics in finding the best agents for patients.
Rachel Britt, PharmD, BCIDP
Advertisement
Britt is a clinical practice specialist, Infectious Diseases, University Health System in San Antonio, Texas.
Articles by Rachel Britt, PharmD, BCIDP
Advertisement
Latest Updated Articles
Considering Alternatives to Vancomycin for MRSAPublished: November 11th 2025 | Updated:
Making Lemonade Out of Lemons: The Effect of Mandatory Infectious Diseases Consultation on Carbapenem Use after Drug ShortagesPublished: October 10th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of November 29 - December 5
2
Early 2025 Influenza Vaccination Trends Following Prior Season and H3N2 Start
3
ACIP Votes on Hepatitis B Vaccine Marks More Confusion, No Supportive Safety Data, and Uncertainty of Public Health Policy
4
CDC ACIP Delays Votes on Hepatitis B Birth Dose Until Tomorrow
5
